10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery – New Study
Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases
Summary
A large-scale study aims to analyze thousands of tumor samples to identify new biomarkers and potential drug targets for cancer and inflammatory diseases. By comprehensively profiling these samples, researchers hope to gain a deeper understanding of the molecular mechanisms driving these diseases. The ultimate goal is to develop more effective and personalized treatments by leveraging the identified biomarkers for early detection, diagnosis, and targeted therapies. This ambitious project promises to accelerate advancements in cancer and inflammatory disease management.
Read more…
This post is part of “Science and Technology News”, Follow for more…!!!
Credits: Source
Disclaimer







